Training

The University of Chicago Clinical Pharmacology and Pharmacogenomics Training Program offers four possible distinct tracks to fit your training and career goals. Training options include:

Clinical Therapeutics (Pharmacology and Pharmacogenomics)

A 2-year personalized training program in any of the broad opportunities within clinical pharmacology and pharmacogenomics. This could, for example, include overlapping joint training with another medical subspecialty or residency program, or dedicated post-doctoral studies in translational research. This track is open to MD’s, PhD’s and PharmD's.

Clinical Therapeutics in Oncology

This unique 4-year program joins comprehensive fellowship training in the Section of Hematology/Oncology, Department of Medicine and in Clinical Pharmacology and Pharmacogenomics, through our American Board of Clinical Pharmacology accredited Fellowship Program. Trainees completing this program will develop expertise in cancer pharmacology and pharmacogenomics. If interested, click here to complete the ERAS application for the University of Chicago Hematology/Oncology Fellowship and indicate your interest in the dual training program on the application. Supplemental application material may be requested. This track is intended for physicians seeking a career in the exciting field of cancer therapeutics.

Pharmacogenomics - Clinical Implementation

This 2-year program provides research focused in the area of pharmacogenomics and pharmacogenomic clinical implementation. Trainees will have the ability to develop clinical research expertise within an established research group with the University of Chicago Center for Personalized Therapeutics. The track is open to PharmD's with a completed clinical residency or PharmD/PhD's.

Clinical Therapeutics in Industry

This 2-year program provides focused academic work in clinical pharmacology and pharmacogenomics in the first year, followed by a year of training largely in an industry setting. Trainees are expected to become board-certified in Clinical Pharmacology, but the program is intended to build a skill set suitable for a career in Industry. The track is open to PhD’s, MD’s and PharmD's with a preference for MD’s interested in oncology.

All training will consist of protected time for mentored research activities.